|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kenji Arima, PhD, and Akihiko Watanabe, PhD, introduce NapaJen Pharma’s technology with a specific focus on solving some of the current challenges of oligonucleotide therapeutics.
|
|
|
Doug Drysdale, President & CEO of Tedor Pharma, Inc., discusses the FLEXITAB technology, his strategy for managing a shift in business model, and how Tedor is addressing the needs of small- and medium-size companies developing innovative and repurposed small molecules for unmet medical needs.
|
|
|
Zack Gurard-Levin, PhD, says with new innovations in assay methodologies, scientists no longer have to make sacrifices to do quality drug discovery research.
|
|
|
Ramesh Jagadeesan, PhD, says that while CDMOs have the capacity to support pharmaceutical companies with their analytical requirements for both small and large-scale projects, the opportunity exists to increase speed to market with innovative thinking.
|
|
|
Crystal Stone and Amanda Coogan indicate that in an era in which the time- and resource-intensive business model of developing blockbuster drugs has been supplanted by a push to move drug candidates through the pipeline with greater speed, accuracy, and quality, RBM and real-time data analytics are becoming a must-have for clinical trials.
|
|
|
Paul Stark, MS, ScD, reviews how and when an interim analysis would be valuable and how, with examples and outcomes, it can be applied in a clinical trial setting.
|
|
|
|
|
|
|
|
|

The Health business of Lubrizol Life Science (LLS Health) partners with customers to speed innovative differentiated pharmaceutical products and medical devices to market. Our team provides multifunctional polymers and excipients, as well as product design, development, and manufacturing services. LLS Health offers high-quality development and production of added value nutraceutical ingredients, providing nutritional and technical solutions for clients’ final products brands in the functional foods and dietary supplements industries. Click here for more.

Headquartered in Nashville,TN PMI BioPharma Solutions is a team of highly experienced life science experts providing rigorous research, pharmaceutical development, and clinical manufacturing services to clients in the pharmaceutical and biotechnology space. We pride ourselves on our abilities, integrity, and persistence in the face of challenge, and will exert maximal effort and ingenuity to achieve your goals. Click here for more.
|
|
|
|
|
|
 |
|
Wondering if investing in a higher purity excipient is really going to pay off? Check out our video web series where we speak to 3 subject matter experts on the benefits of…..
|
|
 |
|
Along with a rapidly expanding global market for innovative lyophilized biologics come increased cost and competitive pressures. Today, it is critical that….
|
|
 |
|
Apollomics, Inc. recent announced the initiation of the Phase 2 portion of the Phase 1/2 clinical trial for APL-101 based on completion of the Phase 1 and approval from the….
|
|
 |
|
The US FDA has recently approved the investigational new drug (IND) application submitted by Octapharma USA for a Phase 3 clinical trial on…
|
|
 |
|
SeraNovo B.V. recently announced it has signed a second License Agreement with Carna Biosciences, Inc., a company engaged in the drug development of….
|
|
|
|
|
|
|
|
|